ConductScience.org, home

Paper3957435

Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.

Haag R. Infection, 1986. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus. Papers, record 3957435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3957435

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
PubMed
Journal
Infection
PubMed
Year
1986
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2019-08-29
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Haag RR

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Muscular DiseasesMajor topic
Staphylococcal InfectionsMajor topic
Animals
Cefazolin
Floxacillin
Fosfomycin
Fusidic Acid
Mice
Mice, Inbred Strains
Microbial Sensitivity Tests
Penicillin G
Rifampin
Species Specificity
Staphylococcus aureus
Vancomycin

Source PubMed

Download CSV of topics

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14488470Fucidin-resistant staphylococci in current hospital practice.J Med Microbiol1973https://conductscience.org/library/papers/4488470PubMed
27116982Treatment of mice infected with methicillin-resistant Staphylococcus aureus.Chemotherapy1982https://conductscience.org/library/papers/7116982PubMed
36915076The role of antibiotic tolerance in the response to treatment of pyelonephritis due to Staphylococcus aureus in rats.J Infect Dis1982https://conductscience.org/library/papers/6915076PubMed
46092279In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.Infection1984https://conductscience.org/library/papers/6092279PubMed
57071562[Sensitivity of bacteria to chemotherapeutic agents (Zurich 1980). Part I. Bacteria isolated from hospital patients].Schweiz Med Wochenschr1982https://conductscience.org/library/papers/7071562PubMed
6475520Serious staphylococcal infections with strains tolerant to bactericidal antibiotics.Arch Intern Med1979https://conductscience.org/library/papers/475520PubMed
76520065The incidence and development of resistance in Staphylococcus aureus from three European countries.J Antimicrob Chemother1984https://conductscience.org/library/papers/6520065PubMed
96979313Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6979313PubMed
1013877818[Staphylococcus strains naturally resistant to methicillin and 5-methyl-3-phenyl-4-iso-oxazolyl-penicillin].Ann Inst Pasteur (Paris)1962https://conductscience.org/library/papers/13877818PubMed
117028601[Comparison of in vitro methods for the determination of the activity of fosfomycin with the efficacy determined in experimentally infected mice (author's transl)].Immun Infekt1981https://conductscience.org/library/papers/7028601PubMed
12349090Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli.J Infect Dis1978https://conductscience.org/library/papers/349090PubMed
133969311Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes.Pediatr Res1985https://conductscience.org/library/papers/3969311PubMed
146903495[Comparison of activity of fosfomycin, oxacillin and penicillin G against staphylococci and micrococci (author's transl)].Dtsch Med Wochenschr1980https://conductscience.org/library/papers/6903495PubMed
156550616Resistance of methicillin-resistant staphylococcus aureus to third-generation cephalosporins.J Infect Dis1983https://conductscience.org/library/papers/6550616PubMed
166549772
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.
J Infect Dis1983https://conductscience.org/library/papers/6549772PubMed
176901593Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6901593PubMed
186320397[Selection of mutant rifampin-resistant Staphylococcus aureus during the therapeutic use of this antibiotic in combinations. 3 cases].Sem Hop1983https://conductscience.org/library/papers/6320397PubMed
196570084Responses of tolerant and nontolerant Staphylococcus aureus strains to methicillin treatment in an experimental infection in mice.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6570084PubMed
206735962Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections.J Antimicrob Chemother1984https://conductscience.org/library/papers/6735962PubMed
215023643Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.J Infect Dis1972https://conductscience.org/library/papers/5023643PubMed

See all 43 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
41182847Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.J Antimicrob Chemother2025https://conductscience.org/library/papers/41182847PubMed
10770759Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10770759PubMed
2921087The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci.Infection1989https://conductscience.org/library/papers/2921087PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3957435

GET https://conductscience.org/api/papers/v1/3957435/references?page=2